<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Vascular endothelium is involved in the regulation of vascular tone, vessel permeability, and <z:mpath ids='MPATH_177'>angiogenesis</z:mpath> </plain></SENT>
<SENT sid="1" pm="."><plain>Vessel tone is determined by the balance of various paracrine vasodilatory and vasoconstrictor factors, most notably nitric <z:chebi fb="177" ids="25741,29356">oxide</z:chebi> (NO) and endothelin-1 </plain></SENT>
<SENT sid="2" pm="."><plain>Not surprisingly, <z:e sem="disease" ids="C0856169" disease_type="Disease or Syndrome" abbrv="">endothelial dysfunction</z:e> is believed to be crucial in the development of the <z:hpo ids='HP_0011010'>chronic</z:hpo> vascular complications of <z:mp ids='MP_0002055'>diabetes</z:mp> </plain></SENT>
<SENT sid="3" pm="."><plain><z:e sem="disease" ids="C0856169" disease_type="Disease or Syndrome" abbrv="">Endothelial dysfunction</z:e>, which may be examined by studying endothelial-dependent vasodilatation in humans, is also disturbed by many of the individual features of the <z:hpo ids='HP_0000855'>insulin resistance</z:hpo> syndrome including <z:hpo ids='HP_0000822'>hypertension</z:hpo>, <z:e sem="disease" ids="C0242339" disease_type="Disease or Syndrome" abbrv="">dyslipidaemia</z:e>, and <z:e sem="disease" ids="C0020456" disease_type="Disease or Syndrome" abbrv="">hyperglycaemia</z:e> </plain></SENT>
<SENT sid="4" pm="."><plain>Therefore, it may be possible that <z:e sem="disease" ids="C0856169" disease_type="Disease or Syndrome" abbrv="">endothelial dysfunction</z:e> could be closely associated with, or even a common antecedent of, the <z:hpo ids='HP_0000855'>insulin resistance</z:hpo> syndrome (IRS) </plain></SENT>
<SENT sid="5" pm="."><plain>There is emerging evidence that impaired endothelial-dependent vasodilatation is present in populations at future risk of <z:mp ids='MP_0002055'>diabetes</z:mp> and even in children of <z:hpo ids='HP_0001518'>low birth weight</z:hpo>, who may exhibit features of the <z:hpo ids='HP_0000855'>insulin resistance</z:hpo> syndrome in later life </plain></SENT>
<SENT sid="6" pm="."><plain><z:e sem="disease" ids="C0856169" disease_type="Disease or Syndrome" abbrv="">Endothelial dysfunction</z:e> is an obvious therapeutic target if the vascular pathology associated with <z:hpo ids='HP_0000855'>insulin resistance</z:hpo> and type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> is to be ameliorated </plain></SENT>
</text></document>